Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  lobular breast carcinoma
Stage/Subtype:  lobular breast carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-12 of 12 for your search:
Start Over
Proton Beam Radiation Therapy or Photon Beam Radiation Therapy in Treating Patients with Non-Metastatic Breast Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 21 and over
Trial IDs: UPCC 19115, NCI-2015-01950, 823440, RTOG 3509, RTOG 3510, UPC 19115, NCT02603341
Accelerated Partial Breast Irradiation in Treating Patients with Low-Risk Stage 0-I Breast Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 50 and over
Trial IDs: 201401160, NCI-2014-00269, NCT02076074
Accelerated Whole Breast Radiotherapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 040807, NCI-2012-00535, CDR0000643276, CINJ-040807, NCT00909909
Radiation Therapy in Treating Patients With Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0818, NCI-2011-01102, NCT01245712
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients with ERBB2 Expressing Disseminated Tumor Cells
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201309084, NCI-2012-03110, 12-X356, NCT01779050
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Hypofractionated Regional Nodal Radiation Therapy in Treating Older Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 50 and over
Trial IDs: MCC-15-10994, NCI-2015-01317, NCT02515110
Fulvestrant with or without Ribociclib in Patients with Recurrent, Unresectable, or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AAAP9506, NCI-2016-01092, NCT02632045
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CLGK974X2101, NCI-2011-03693, 2011-000495-33, NCT01351103
Vaccine Therapy with or without Durvalumab in Treating Patients with Stage II-III Triple Negative Breast Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-132, NCI-2016-01368, NCT02826434
Broccoli Sprout Extract in Treating Patients with Breast Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: I 211911, NCI-2012-01770, NCT01753908
Caloric Restriction in Treating Patients with Early Stage Breast Cancer Undergoing Surgery and Radiation Therapy
Status: Temporarily closed
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12G.616, NCI-2013-00611, 2012-94, NCT01819233
Start Over